SAMSUNG PHARM. Co., Ltd.
SAMSUNG PHARM. Co., Ltd. (KRX: 001360) is trading at ₩1,376.00, about ₹99 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 4.04% today. SAMSUNG PHARM. is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩1,375.00
Today's high
₩1,439.00
52 week low
₩1,140.00
52 week high
₩2,320.00
001360 opened at ₩1,434.00, closed previously at ₩1,434.00, and has traded between ₩1,140.00 and ₩2,320.00 over the past 52 weeks.
About
SAMSUNG PHARM. Co., LTD. is a South Korean pharmaceutical company engaged in the manufacturing and distribution of a wide array of medical products. Its extensive portfolio includes a variety of prescription medications, encompassing treatments for conditions such as cancer (immunotherapy), pain, fever, and inflammation, obesity, high blood pressure, and arterial hardening, along with remedies for digestive disorders, phlegm, enzyme deficiencies, and osteoporosis. The company also supplies transfusion agents, skeletal muscle relaxants, antispasmodics, mixed vitamins, and antibiotics. Beyond these, SAMSUNG PHARM. provides general health and wellness products, including digestive aids, liver and circulatory system medications, cold remedies, nutritional supplements, health tonics, vitamins, energy drinks, and functional foods. Founded in 1929, the firm maintains its headquarters in Hwaseong-si, South Korea.
Key statistics
Avg. volume
449.86K
Market cap
₩129.51B
P/E Ratio
-0.95
Price-to-sales ratio
3.03
Enterprise value
₩150.60B
Free cash flow yield
-7.01%
Debt-to-equity ratio
0.26
Return on equity
9.54%
ROIC
-13.63%
Beta
0.76
Dividend yield
0.00%
Last dividend
₩0.00
Financial overview
Revenue
₩46.07B
Earnings per share
₩122.66
Free cash flow
-₩10.10B
Net profit margin
-320.93%
Gross margin
38.51%
EBITDA
-₩18.06B
Revenue growth
4.02%
Similar securities
This is not an investment recommendation
SAMSUNG PHARM. for Indian investors
SAMSUNG PHARM. is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on SAMSUNG PHARM. for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneSAMSUNG PHARM. does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can I buy SAMSUNG PHARM. on Paasa?
SAMSUNG PHARM. (001360) has been listed on the Korea Exchange since 2000, in the Drug Manufacturers - Specialty & Generic industry. SAMSUNG PHARM. is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one SAMSUNG PHARM. share cost in rupees?
One SAMSUNG PHARM. share is ₩1,376.00 — about ₹99 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the SAMSUNG PHARM. price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on SAMSUNG PHARM. shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the SAMSUNG PHARM. price.
Does SAMSUNG PHARM. pay a dividend?
No. SAMSUNG PHARM. does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare SAMSUNG PHARM. shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on SAMSUNG PHARM.?
Yes. SAMSUNG PHARM. is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.